Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection
HIV-1 subtype C (C-HIV) is responsible for most HIV-1 cases worldwide. Although the pathogenesis of C-HIV is thought to predominantly involve CCR5-restricted (R5) strains, we do not have a firm understanding of how frequently CXCR4-using (X4 and R5X4) variants emerge in subjects with progressive C-H...
| Main Authors: | Jakobsen, M., Cashin, K., Roche, M., Sterjovski, J., Ellett, A., Borm, K., Flynn, J., Erikstrup, C., Gouillou, M., Gray, L., Saksena, N., Wang, B., Purcell, D., Kallestrup, P., Zinyama-Gutsire, R., Gomo, E., Ullum, H., Østergaard, L., Lee, B., Ramsland, Paul, Churchill, M., Gorry, P. |
|---|---|
| Format: | Journal Article |
| Published: |
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/37710 |
Similar Items
Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages
by: Cashin, K., et al.
Published: (2011)
by: Cashin, K., et al.
Published: (2011)
HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropism
by: Roche, M., et al.
Published: (2011)
by: Roche, M., et al.
Published: (2011)
Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12
by: Sterjovski, J., et al.
Published: (2012)
by: Sterjovski, J., et al.
Published: (2012)
CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity
by: Sterjovski, J., et al.
Published: (2011)
by: Sterjovski, J., et al.
Published: (2011)
An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes
by: Sterjovski, J., et al.
Published: (2010)
by: Sterjovski, J., et al.
Published: (2010)
Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5
by: Salimi, H., et al.
Published: (2013)
by: Salimi, H., et al.
Published: (2013)
Covariance of Charged Amino Acids at Positions 322 and 440 of HIV-1 Env Contributes to Coreceptor Specificity of Subtype B Viruses, and Can Be Used to Improve the Performance of V3 Sequence-Based Coreceptor Usage Prediction Algorithms
by: Cashin, K., et al.
Published: (2014)
by: Cashin, K., et al.
Published: (2014)
A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations
by: Roche, M., et al.
Published: (2013)
by: Roche, M., et al.
Published: (2013)
Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues
by: Gray, L., et al.
Published: (2011)
by: Gray, L., et al.
Published: (2011)
Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)
by: Marini, S., et al.
Published: (2016)
Compartmentalised signalling and trafficking of CXCR4 and ACKR3
by: Karsai, Noemi
Published: (2025)
by: Karsai, Noemi
Published: (2025)
The enzyme activities of Caf1 and Ccr4 are both required for deadenylation by the human Ccr4-Not nuclease module
by: Maryati, Marayti, et al.
Published: (2015)
by: Maryati, Marayti, et al.
Published: (2015)
Dynamics of ligand and nanobody binding at CXCR4/EGFR complexes
by: Comez, Dehan
Published: (2025)
by: Comez, Dehan
Published: (2025)
Effects of CXCR4 siRNA/dextran-spermine nanoparticles on CXCR4 expression and serum LDH levels in a mouse model of colorectal cancer metastasis to the liver.
by: Abedini, Fatemeh, et al.
Published: (2011)
by: Abedini, Fatemeh, et al.
Published: (2011)
High prevalence of ccrC and ccrA2 type cassette chromosome recombinase (ccr) found in the staphylococcal cassette chromosome (SCC) elements of coagulase negative staphylococcus (CoNS) species isolated from UKMMC
by: Nurul Azirah, MS, et al.
Published: (2011)
by: Nurul Azirah, MS, et al.
Published: (2011)
Investigating the mode of action of intracellular loop 1 pepducins at the CXCR4 receptor
by: Caspar, Birgit
Published: (2019)
by: Caspar, Birgit
Published: (2019)
Molecular analysis of the Ccr4-Not deadenylase: relevance to human disease
by: Airhihen, Blessing
Published: (2017)
by: Airhihen, Blessing
Published: (2017)
Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis
by: Shanmugam, M., et al.
Published: (2018)
by: Shanmugam, M., et al.
Published: (2018)
Copy number variation of c-c chemokine ligand 3-like 1 (CCL3L1), c-c chemokine receptor type 5 (CCR5) and CCR2 polymorphisms on the outcomes of antiretroviral therapy among Malaysian HIV patients
by: Mohamad Isa, Irma Izani
Published: (2020)
by: Mohamad Isa, Irma Izani
Published: (2020)
Biochemical analysis of the nuclease module of the human Ccr4-Not deadenylase complex
by: Maryati, Maryati
Published: (2015)
by: Maryati, Maryati
Published: (2015)
Analysis of the Ccr4-Not deadenylase complex: a biochemical and computational approach
by: Balacco, Dario Leonardo
Published: (2017)
by: Balacco, Dario Leonardo
Published: (2017)
Characterisation of AmCCR1 and pseudoCOMTAm promoters in Acacia mangium
by: Azmah Abdul Latif,, et al.
Published: (2020)
by: Azmah Abdul Latif,, et al.
Published: (2020)
Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma
by: Manu, K., et al.
Published: (2013)
by: Manu, K., et al.
Published: (2013)
Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4
by: Manu, K., et al.
Published: (2011)
by: Manu, K., et al.
Published: (2011)
Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer
by: Sarchio, Seri Narti Edayu, et al.
Published: (2014)
by: Sarchio, Seri Narti Edayu, et al.
Published: (2014)
Examining the mechanism of action of small-molecule negative allosteric modulators of the human chemokine receptor CXCR2
by: Nesheva, Desislava
Published: (2022)
by: Nesheva, Desislava
Published: (2022)
Small molecule-based fluorescent probes as tool compounds for chemokine receptors CXCR4 and ACKR3
by: Dekkers, Sebastian
Published: (2019)
by: Dekkers, Sebastian
Published: (2019)
CCR5 polymorphisms and its relationship with HIV susceptibility, viral load and CD4 count in early antiretroviral therapy among HIV patients in Selangor and Terengganu
by: Mohamad Isa, Irma Izani, et al.
Published: (2023)
by: Mohamad Isa, Irma Izani, et al.
Published: (2023)
Effects of CXCR4 Silencing by Sirna Engrafted Cotionized Dextran in Mouse Models of Colorectal Cancer and Liver Metastasis
by: Abedini, Fatemeh
Published: (2011)
by: Abedini, Fatemeh
Published: (2011)
CCL3L1 copy number, CCR5 genotype and susceptibility to tuberculosis
by: Carpenter, Danielle, et al.
Published: (2014)
by: Carpenter, Danielle, et al.
Published: (2014)
Primary acute dengue and the deletion in chemokine receptor 5 (CCR5D32)
by: Brestovac, Brian, et al.
Published: (2014)
by: Brestovac, Brian, et al.
Published: (2014)
Biochemical characterisation of the human Ccr4-Not complex: core complex assembly and deadenylation activity
by: Pavanello, Lorenzo
Published: (2018)
by: Pavanello, Lorenzo
Published: (2018)
Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model
by: Shanmugam, M., et al.
Published: (2011)
by: Shanmugam, M., et al.
Published: (2011)
Discovery of AZD-2098 and AZD-1678, two potent and bioavailable CCR4 receptor antagonists
by: Kindon, Nicholas, et al.
Published: (2017)
by: Kindon, Nicholas, et al.
Published: (2017)
Development of Hybrid Model From CCR-I and SBM-I for Measuring Mix Efficiency Level
by: Asbullah, Muhammad Asyraf
Published: (2010)
by: Asbullah, Muhammad Asyraf
Published: (2010)
Post-transcriptional control of tumor cell autonomous metastatic potential by the CCR4-NOT deadenylase CNOT7
by: Faraji, Farhoud, et al.
Published: (2016)
by: Faraji, Farhoud, et al.
Published: (2016)
Disease trends over time and CD4+CCR5+ T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus
by: Baragetti, A., et al.
Published: (2017)
by: Baragetti, A., et al.
Published: (2017)
Measuring the performance of Malaysian universities using Charnes, Cooper and Rhodes (CCR) and slack-based measure (SBM) models
by: Norfarziah Adna,, et al.
Published: (2022)
by: Norfarziah Adna,, et al.
Published: (2022)
Reconstitution of the Core Ccr4-Not Complex and Evidence for Possible Interaction between YTHDF2 and Human CNOT9
by: Gong, Yutong
Published: (2025)
by: Gong, Yutong
Published: (2025)
Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1
by: Telwatte, S., et al.
Published: (2011)
by: Telwatte, S., et al.
Published: (2011)
Similar Items
-
Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages
by: Cashin, K., et al.
Published: (2011) -
HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropism
by: Roche, M., et al.
Published: (2011) -
Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12
by: Sterjovski, J., et al.
Published: (2012) -
CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity
by: Sterjovski, J., et al.
Published: (2011) -
An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes
by: Sterjovski, J., et al.
Published: (2010)